Algorithms work fast
Advanced processing runs in the background while you focus on what matters. Results come back clean and ready to use.
We are an AI/ML leader with a mission to deliver precision therapies for every patient with fibrotic or autoimmune disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Lorem ipsum dolor sit, consectetur adipiscing elit. Suspendisse varius enim eros elementum tristique. Duis cursus, mi quis viverra ornare, eros interdum nulla. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum


Advanced processing runs in the background while you focus on what matters. Results come back clean and ready to use.
Visual dashboards show you exactly what the data means. No guessing. No confusion. Just clarity.
Take your findings wherever they need to go. Multiple formats, seamless integration, your way.
Take your findings wherever they need to go. Multiple formats, seamless integration, your way.
Our unique and proprietary database of single-cell and spatial disease datasets across inflammation and immunity.
Provides the scale and diversity of human data needed to train GenAI models capable of uncovering novel biology.

Pathosignatures delivers a holistic approach to cell prioritisation, enabling more sensitive, powerful, and high-resolution identification of disease-associated cells and tissue domains.
By leveraging single-cell, spatial, and genetics data to rank pathogenic cell types and providing independent validation, it helps reduce risk and increase confidence in discovery decisions.


Discover targets beyond the reach of traditional methods. Cell 2 Target pinpoints cell-specific and combinatorial opportunities within disease-relevant tissue domains, enabling the identification of safer and more precise therapeutic molecules.



Patient Selection utilises EnsoAI domains to generate patient-specific domain fingerprints. Domain fingerprints stratifies patients into biologically meaningful subgroups to support selection of the right patients for the right therapy.



The EnsoAI platform extracts spatial signals from complex biological datasets to reveal how tissues evolve throughout disease progression. By integrating single-cell and spatial data, it refines cell-state resolution, uncovers functional tissue architecture, and identifies disease-specific biology. These insights power predictive simulations of tissue evolution, signalling dynamics, treatment response, and in silico perturbation experiments, enabling deeper understanding and more informed therapeutic development.




Four dimensions of disease. One integrated platform.
EnsoDB is our unique and proprietary database collating vast single-cell and spatial disease datasets across inflammation and immunity. It provides the scale and diversity of human data needed to train EnsoAI models capable of uncovering novel biology.
PathoSignatures synthesizes single-cell, spatial, and genetics data to rank pathogenic cell types and provide validation from multiple sources. This helps reduce risk and increase confidence in development decisions.


Cell 2 Target pinpoints cell-specific and combinatorial opportunities within 3D tissue contexts relevant to disease. This enables the identification of safer and more therapeutic molecules.

Patient Selection uses EnsoAI to stratify patients into biologically meaningful subgroups to inform both therapeutic and clinical design. Characterizing the variety in disease will be key to precision medicine evolving beyond 'one-size-fits-all' therapies.



The EnsoAI platform harnesses all our datasets to reveal how tissues evolve as disease progresses. These insights power predictive simulations of tissue evolution, treatment response, and in silico simulations, enabling smarter therapeutic development.


Our work is guided by five key values that speak to our commitment to scientific integrity, rigour and unlocking progress through teamwork.
We are scientists driven to turn insight into ground-breaking medicines.
We develop transformative new therapies for patients facing serious disease
We are driven by scientific curiosity and tenacity
We strive for excellence in exuection and achievement as one team
We are committed to meaningful dialogue, empathy, and intellectual humility
We embrace bold ideas and take calculated risks

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Protein Biotherapeutics
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Protein Biotherapeutics
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Department
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
We're here to collaborate.